Inactive Instrument

Pieris Pharmaceuticals

Stocks

PIRS

US7207952026

Transcript : Palvella Therapeutics, Inc., Pieris Pharmaceuticals, Inc. - M&A Call

Published on 07/24/2024 at 01:30 pm BST

S&P Capital IQ

Add MarketScreener to your sources

Presentation Operator Message
Operator (Operator)

Greetings. Welcome to Palvella Therapeutics and Pieris Pharmaceuticals announcement of their merger agreement. [Operator Instructions] Please note,

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about Pieris Pharmaceuticals

12/12/24	Palvella Therapeutics, Inc.(NasdaqCM:PIRS) dropped from NASDAQ Composite Index	CI
12/12/24	Palvella Therapeutics, Inc. completed the acquisition of Pieris Pharmaceuticals, Inc. in a reverse merger transaction.	CI
13/11/24	Pieris Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
07/11/24	Pieris Pharmaceuticals' Merger Target Palvella Doses First Patient in Phase 3 Trial of Lymphatic Drug	MT
14/08/24	Pieris Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
06/08/24	Pieris Pharmaceuticals, Inc. announced that it has received funding	CI
24/07/24	Top Midday Gainers	MT
24/07/24	Pieris Pharmaceuticals, Palvella Therapeutics Agree to Merge; Pieris Shares Jump	MT
24/07/24	Traders Digest Alphabet, Tesla Results, Fueling Premarket Losses for US Equity Futures	MT
24/07/24	Palvella Therapeutics, Inc., Pieris Pharmaceuticals, Inc. - M&A Call
24/07/24	Top Premarket Gainers	MT
24/07/24	Pieris Pharmaceuticals, Inc. Announces Stepping Down of Shane Olwill as Senior Vice President and Chief Development Officer	CI
24/07/24	Palvella Therapeutics, Inc. and Pieris Pharmaceuticals, Inc. Announce Definitive Merger Agreement	CI
23/07/24	Palvella Therapeutics, Inc. agreed to acquire Pieris Pharmaceuticals, Inc. in a reverse merger transaction.	CI
03/07/24	Pieris Pharmaceuticals, Inc., Pieris Pharmaceuticals GmbH, es Laboratoires Servier and Institut de Recherches Internationales Servier Announce Termination of A Material Definitive Agreement	CI

Chart Pieris Pharmaceuticals

Duration

Period

PIRS: Dynamic Chart

Company Profile

Sector

More about the company